Spruce Biosciences falls on bigger-than-expected Q1 loss
** Shares of biopharma co Spruce Biosciences Inc SPRB.O
down 4.04% at $2.14
** Co reports Q1 loss of 40 cents per share vs analysts'
ests of a loss of 46 cents per share - Refinitiv
** Posts cash, cash equivalents and investments at $118.6
mln as of March 31, 2023
** SPRB stock up 91.82% YTD
(Reporting by Rupali Chaudhary in Bengaluru)
((Rupali.chaudhary@thomsonreuters.com))
Recent news on Spruce Biosciences
See all newsSpruce Biosciences, Inc. reports results for the quarter ended June 30 - Earnings Summary
Spruce Biosciences Q2 net loss widens on higher expenses
Spruce Biosciences, Inc. expected to post a loss of $5.80 a share - Earnings Preview
Brief: Spruce Biosciences Appoints Adrian Quartel, M.D., Ffpm, As Chief Medical Officer
Brief: Spruce Biosciences Announces Data Presentation At The 18Th International MPS Symposium